Hover over the bar plot to get the GO term. Differentially targeted genes and TFs were computed by comparing a cancer network to all other cancers.
Tool description
PANDA reconstructs a gene regulatory network using TF PPI, TF DNA binding motif, and gene expression samples. You can check the phenotypic information for the clinical variables of the samples that were used to reconstruct the network.
# | Tissue | Tool | netZoo release | Network |
PPI |
Motif | Expression | Regulator | nReg | Genes | Data | Samples | Precision |
Reference |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Adrenocortical carcinoma | PANDA | netZooR 0.9 | TF | 644 | 29375 | TCGA | 79 | D |
Variable description
This is a description of the primary clinical variables of the gene expression samples that were used to generate the gene regulatory network.
Sample |
Gender | Race | Stage |
Vital status | Age |
Days to last follow up | Tumor ID |
---|---|---|---|---|---|---|---|
TCGA-OR-A5J5-01A | MALE | WHITE | Stage III | Dead | 30 | [Not Available] | ACC |
TCGA-OR-A5K4-01A | FEMALE | WHITE | Stage III | Alive | 64 | 528 | ACC |
TCGA-OR-A5KU-01A | FEMALE | WHITE | Stage II | Alive | 37 | 4673 | ACC |
TCGA-OR-A5JK-01A | MALE | WHITE | Stage IV | Alive | 49 | 1255 | ACC |
TCGA-OR-A5J8-01A | MALE | WHITE | Stage III | Dead | 66 | [Not Available] | ACC |
TCGA-OR-A5KW-01A | FEMALE | WHITE | Stage III | Alive | 55 | 1525 | ACC |
TCGA-OR-A5L9-01A | FEMALE | WHITE | Stage II | Alive | 53 | 645 | ACC |
TCGA-OR-A5KY-01A | FEMALE | WHITE | Stage IV | Dead | 23 | [Not Available] | ACC |
TCGA-OR-A5J3-01A | FEMALE | WHITE | Stage III | Alive | 23 | 1942 | ACC |
TCGA-PA-A5YG-01A | MALE | WHITE | Stage II | Alive | 51 | 470 | ACC |
TCGA-OR-A5JW-01A | MALE | WHITE | Stage II | Alive | 47 | 1924 | ACC |
TCGA-OR-A5LN-01A | FEMALE | [Not Evaluated] | Stage II | Alive | 31 | 1916 | ACC |
TCGA-OR-A5JO-01A | FEMALE | WHITE | Stage I | Alive | 26 | 889 | ACC |
TCGA-OR-A5JD-01A | FEMALE | WHITE | Stage II | Alive | 57 | 2782 | ACC |
TCGA-PK-A5H8-01A | MALE | WHITE | Stage II | Alive | 42 | 3240 | ACC |
TCGA-OR-A5JJ-01A | MALE | WHITE | Stage IV | Alive | 65 | 309 | ACC |
TCGA-OR-A5JE-01A | FEMALE | WHITE | Stage I | Dead | 17 | [Not Available] | ACC |
TCGA-OR-A5LT-01A | MALE | [Not Evaluated] | Stage III | Alive | 57 | 365 | ACC |
TCGA-OR-A5L4-01A | FEMALE | WHITE | Stage III | Alive | 48 | 724 | ACC |
TCGA-OR-A5LB-01A | MALE | WHITE | Stage IV | Dead | 59 | [Not Available] | ACC |
TCGA-OR-A5JI-01A | MALE | WHITE | Stage I | Alive | 22 | 1424 | ACC |
TCGA-OR-A5JZ-01A | MALE | WHITE | Stage II | Alive | 60 | 211 | ACC |
TCGA-OR-A5LR-01A | FEMALE | [Not Evaluated] | Stage II | Alive | 30 | 639 | ACC |
TCGA-OR-A5LG-01A | MALE | WHITE | Stage III | Alive | 46 | 1589 | ACC |
TCGA-OR-A5K8-01A | MALE | WHITE | Stage II | Alive | 39 | 504 | ACC |
TCGA-OR-A5JS-01A | FEMALE | WHITE | Stage II | Alive | 65 | 383 | ACC |
TCGA-OR-A5JR-01A | MALE | WHITE | Stage I | Alive | 45 | 3688 | ACC |
TCGA-OR-A5JA-01A | FEMALE | WHITE | Stage IV | Dead | 53 | [Not Available] | ACC |
TCGA-OR-A5JP-01A | MALE | WHITE | Stage II | Alive | 40 | 149 | ACC |
TCGA-OR-A5JQ-01A | FEMALE | WHITE | Stage II | Alive | 26 | 674 | ACC |
TCGA-PK-A5HA-01A | MALE | [Unknown] | Stage I | Alive | 63 | 830 | ACC |
TCGA-OR-A5LA-01A | FEMALE | WHITE | Stage II | Alive | 52 | 487 | ACC |
TCGA-PK-A5H9-01A | FEMALE | ASIAN | Stage II | Alive | 27 | 307 | ACC |
TCGA-OR-A5KO-01A | FEMALE | WHITE | Stage IV | Alive | 39 | 1414 | ACC |
TCGA-OR-A5JB-01A | MALE | WHITE | Stage IV | Dead | 52 | [Not Available] | ACC |
TCGA-P6-A5OG-01A | FEMALE | WHITE | Stage IV | Dead | 45 | [Not Available] | ACC |
TCGA-OR-A5KZ-01A | MALE | WHITE | Stage II | Dead | 42 | [Not Available] | ACC |
TCGA-OR-A5J9-01A | FEMALE | WHITE | Stage II | Alive | 22 | 1183 | ACC |
TCGA-OR-A5LK-01A | MALE | [Not Evaluated] | Stage II | Alive | 62 | 2222 | ACC |
TCGA-OR-A5K2-01A | FEMALE | WHITE | Stage III | Dead | 32 | [Not Available] | ACC |
TCGA-OR-A5L8-01A | FEMALE | WHITE | Stage II | Alive | 36 | 555 | ACC |
TCGA-OR-A5KV-01A | FEMALE | WHITE | Stage III | Alive | 17 | 3659 | ACC |
TCGA-OR-A5LH-01A | FEMALE | WHITE | Stage II | Dead | 36 | [Not Available] | ACC |
TCGA-OR-A5J7-01A | FEMALE | WHITE | Stage III | Dead | 30 | [Not Available] | ACC |
TCGA-OR-A5L6-01A | MALE | WHITE | Stage II | Alive | 60 | 628 | ACC |
TCGA-OR-A5K6-01A | FEMALE | WHITE | Stage II | Alive | 56 | 1130 | ACC |
TCGA-P6-A5OF-01A | FEMALE | WHITE | Stage III | Dead | 55 | [Not Available] | ACC |
TCGA-OR-A5JY-01A | FEMALE | WHITE | Stage IV | Dead | 68 | [Not Available] | ACC |
TCGA-OU-A5PI-01A | FEMALE | WHITE | Stage IV | Alive | 53 | 709 | ACC |
TCGA-OR-A5LP-01A | FEMALE | [Not Evaluated] | Stage II | Alive | 37 | 1583 | ACC |
TCGA-OR-A5LE-01A | MALE | WHITE | Stage II | Dead | 14 | [Not Available] | ACC |
TCGA-OR-A5K1-01A | MALE | WHITE | Stage II | Alive | 48 | 2723 | ACC |
TCGA-OR-A5J6-01A | FEMALE | BLACK OR AFRICAN AMERICAN | Stage II | Alive | 29 | 2428 | ACC |
TCGA-OR-A5K5-01A | FEMALE | WHITE | Stage III | Alive | 59 | 253 | ACC |
TCGA-OR-A5JM-01A | FEMALE | WHITE | Stage IV | Dead | 25 | [Not Available] | ACC |
TCGA-OR-A5LC-01A | FEMALE | WHITE | Stage IV | Dead | 71 | [Not Available] | ACC |
TCGA-OR-A5J2-01A | FEMALE | WHITE | Stage IV | Dead | 44 | [Not Available] | ACC |
TCGA-OR-A5J1-01A | MALE | WHITE | Stage II | Dead | 58 | [Not Available] | ACC |
TCGA-OR-A5JV-01A | MALE | WHITE | Stage II | Alive | 55 | 1541 | ACC |
TCGA-OR-A5K9-01A | FEMALE | WHITE | Stage II | Dead | 61 | [Not Available] | ACC |
TCGA-OR-A5K0-01A | FEMALE | WHITE | Stage II | Alive | 69 | 1029 | ACC |
TCGA-OR-A5JG-01A | MALE | WHITE | Stage IV | Dead | 61 | [Not Available] | ACC |
TCGA-OR-A5LO-01A | FEMALE | [Not Evaluated] | Stage II | Alive | 61 | 1949 | ACC |
TCGA-OR-A5JF-01A | FEMALE | WHITE | Stage II | Alive | 69 | 1259 | ACC |
TCGA-OR-A5JX-01A | MALE | WHITE | Stage III | Alive | 50 | 950 | ACC |
TCGA-OR-A5KT-01A | FEMALE | WHITE | Stage I | Alive | 44 | 2673 | ACC |
TCGA-OR-A5LD-01A | MALE | WHITE | Stage III | Dead | 52 | [Not Available] | ACC |
TCGA-OR-A5LJ-01A | FEMALE | WHITE | Stage IV | Dead | 54 | [Not Available] | ACC |
TCGA-OR-A5KX-01A | FEMALE | WHITE | Stage III | Alive | 25 | 1091 | ACC |
TCGA-OR-A5LM-01A | MALE | [Not Evaluated] | Stage II | Alive | 23 | 1858 | ACC |
TCGA-PK-A5HB-01A | MALE | [Unknown] | [Not Available] | Alive | 63 | 1293 | ACC |
TCGA-OR-A5L3-01A | FEMALE | WHITE | Stage I | Alive | 67 | 3897 | ACC |
TCGA-OR-A5LS-01A | FEMALE | [Not Evaluated] | Stage II | Alive | 34 | 882 | ACC |
TCGA-OR-A5LL-01A | FEMALE | [Not Evaluated] | Stage II | Dead | 75 | [Not Available] | ACC |
TCGA-OR-A5L5-01A | FEMALE | WHITE | Stage I | Alive | 77 | 840 | ACC |
TCGA-OR-A5K3-01A | MALE | WHITE | Stage II | Alive | 53 | 2842 | ACC |
TCGA-OR-A5JL-01A | FEMALE | WHITE | Stage I | Alive | 36 | 670 | ACC |
TCGA-OR-A5JC-01A | MALE | WHITE | [Not Available] | Dead | 37 | [Not Available] | ACC |
TCGA-OR-A5JT-01A | FEMALE | WHITE | Stage II | Alive | 65 | 488 | ACC |
Sample | Gender | Race | Stage | Status | Age | Days to follow up | Tumor ID |